Comparison of Combined/Carvedilol Moderate Dose Atorvastatin to Single High Dose Atorvastatin for the Prevention of Contrast-Induced Nephropathy after Cardiac Catheterization

THE EFFECT OF ADMINISTRATION OF ASCORBIC ACID IN PREVENTION OF CONTRAST INDUCED NEPHROPATHY IN PATIENTS WITH RENAL IMPAIRMENT UNDERGOING CORONARY INTERVENTION

Rosuvastatin for reduction of myocardial damage during coronary intervention

PRECISE-DAPT score as a predictor for contrast-induced acute kidney injury in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary interventio

Risk Factors of Contrast-Induced Nephropathy after Percutaneous Coronary Interventions: An Observational Study

ROSUVASTATIN: A POTENT STATIN FOR MANAGEMENT OF INTESTINAL ISCHEMIA/REPERFUSION-INDUCED MULTIPLE ORGAN DYFUNCTION SYNDROME

EFFECTS OF ROSUVASTATIN IN EXPERIMENTALLY-INDUCED CARDIAC ISCHEMIA AND ON AORTIC VASCULAR REACTIVITY.

Pre-Contrast Hemogram-Derived Indices as Predictors for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention

The PRECISE-DAPT Score as a Predictor of Contrast Induced Nephropathy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention

Silymarin for the Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction